8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Aug 15, 2023 · 2y ago · Accession 0000950170-23-042631
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Damora Therapeutics, Inc.
- Ticker
- DMRA
- CIK
- 1800315
- Form type
- 8-K
- Filing date
- Aug 15, 2023
- Report date
- Aug 15, 2023
- Document
- glto-20230815.htm
- Size
- 256 KB